SCHEMBL5783649

SCHEMBL5783649

CC(C)C(=O)NC1(c2ccccc2)CCN(C(=O)NC(CNC(=O)N2CCC3(CC2)C(=O)N(Cc2ccccc2)CN3c2ccccc2)C(=O)O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1L1 Q9UHC9 2/20 0.42
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
BDKRB2 P30411 1/20 0.39
OPRL1 P41146 5/20 0.39
OPRM1 P35372 4/20 0.39
OPRK1 P41145 4/20 0.39
OPRD1 P41143 3/20 0.39
ENPP2 Q13822 2/20 0.39
MEN1 O00255 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779267 0.92 OPRM1 (0.45) NPC1L1CTSBCTSSCTSKBDKRB2
SCHEMBL6481444 0.92 TACR2 (0.43) NPC1L1CTSBCTSSCTSKBDKRB2
SCHEMBL6475394 0.92 NPC1L1 (0.44) NPC1L1CTSBCTSSCTSKBDKRB2
SCHEMBL5781283 0.91 OPRL1 (0.47) NPC1L1BDKRB2OPRL1OPRM1OPRK1
SCHEMBL5782674 0.91 NPC1L1 (0.42) NPC1L1BDKRB2OPRL1OPRM1OPRK1
SCHEMBL5782275 0.89 ENPP2 (0.45) NPC1L1CTSBCTSSCTSKBDKRB2
SCHEMBL5782629 0.89 OPRM1 (0.46) NPC1L1BDKRB2OPRL1OPRM1OPRK1
SCHEMBL5781330 0.85 NPC1L1 (0.44) NPC1L1BDKRB2OPRL1OPRM1OPRK1
SCHEMBL5781256 0.85 OPRM1 (0.47) NPC1L1BDKRB2OPRL1OPRM1OPRK1
SCHEMBL5779633 0.84 OPRM1 (0.46) NPC1L1BDKRB2OPRL1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1329451-B1 SPIRO COMPOUNDS AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES (JP) 2006-08-23 EP disclosed
US-6919349-B2 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient TORAY INDUSTRIES, INC. (JP) 2005-07-19 US disclosed
US-20040087574-A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient TORAY INDUSTRIES INC. (JP) 2004-05-06 US disclosed
EP-1329451-A1 SPIRO COMPOUNDS AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2003-07-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087574-A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient VCAM1, ICAM1, SELL NPC1L1 2533/4885CTSB 2017/4885CTSS 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.